基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
We previously found that polydatin could attenuate renal oxidative stress in diabetic mice and improve renal fibrosis.Recent evidence shows that NADPH oxidase 4 (Nox4)-derived reactive oxygen species (ROS) contribute to inflammatory and fibrotic processes in diabetic kidneys.In this study we investigated whether polydatin attenuated renal fibrosis by regulating Nox4 in vitro and in vivo.In high glucose-treated rat glomerular mesangial cells,polydatin significantly decreased the protein levels of Nox4 by promoting its K48-linked polyubiquitination,thus inhibited the production of ROS,and eventually decreasing the expression of fibronectin (FN) and intercellular adhesion molecule-1 (ICAM-1),the main factors that exacerbate diabetic renal fibrosis.OverexpresSion of Nox4 abolished the inhibitory effects of polydatin on FN and ICAM-1 expression;In addition,the expression of ConneXin32 (CX32) was significantly decreased,which was restored by polydatin treatment.Cx32 interacted with Nox4 and reduced its protein levels.Knockdown of Cx32 abolished the inhibitory effects of polydatin on the expresSion FN and ICAM-1.In the kidneys of streptozocin-induced diabetic mice,administration of polydatin (100 mg·kg-1·d-1,ig,6 days a week for 12 weeks) increased Cx32 expression and reduced Nox4 expression,decreased renal oxidative stress levels and the expression of fibrotic factors,eventually attenuating renal injury and fibrosis.In conclusion,polydatin promotes K48-linked polyubiquitination and degradation of Nox4 by restoring Cx32 expression,thereby decreasing renal oxidative stress levels and ultimately ameliorating the pathological progress of diabetic renal fibrosis.Thus,polydatin reduces renal oxidative stress levels and attenuates diabetic renal fibrosis through regulating the Cx32-Nox4 signaling pathway.
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway
来源期刊 中国药理学报(英文版) 学科
关键词
年,卷(期) 2020,(12) 所属期刊栏目 Renal Pharmacology
研究方向 页码范围 1587-1596
页数 10页 分类号
字数 语种 英文
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (34)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2001(1)
  • 参考文献(1)
  • 二级参考文献(0)
2004(1)
  • 参考文献(1)
  • 二级参考文献(0)
2006(2)
  • 参考文献(2)
  • 二级参考文献(0)
2007(1)
  • 参考文献(1)
  • 二级参考文献(0)
2008(1)
  • 参考文献(1)
  • 二级参考文献(0)
2009(1)
  • 参考文献(1)
  • 二级参考文献(0)
2010(1)
  • 参考文献(1)
  • 二级参考文献(0)
2011(2)
  • 参考文献(2)
  • 二级参考文献(0)
2012(2)
  • 参考文献(2)
  • 二级参考文献(0)
2013(4)
  • 参考文献(4)
  • 二级参考文献(0)
2014(3)
  • 参考文献(3)
  • 二级参考文献(0)
2015(1)
  • 参考文献(1)
  • 二级参考文献(0)
2016(4)
  • 参考文献(4)
  • 二级参考文献(0)
2017(5)
  • 参考文献(5)
  • 二级参考文献(0)
2018(3)
  • 参考文献(3)
  • 二级参考文献(0)
2019(1)
  • 参考文献(1)
  • 二级参考文献(0)
2020(1)
  • 参考文献(1)
  • 二级参考文献(0)
2020(1)
  • 参考文献(1)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
引文网络交叉学科
相关学者/机构
期刊影响力
中国药理学报(英文版)
月刊
1671-4083
31-1347/R
大16开
上海市太原路294号
4-295
1980
eng
出版文献量(篇)
4416
总下载数(次)
2
总被引数(次)
42236
  • 期刊分类
  • 期刊(年)
  • 期刊(期)
  • 期刊推荐
论文1v1指导